MRI - Brain + Spectroscopy with Contrast
MRI – Brain + Spectroscopy with Contrast is a highly advanced imaging procedure that combines conventional brain MRI, contrast-enhanced imaging, and Magnetic Resonance Spectroscopy (MRS) to provide both structural and biochemical information about brain tissues.
The contrast agent (gadolinium-based) enhances visualization of abnormalities such as tumors, infections, inflammation, and areas with disrupted blood-brain barrier. Magnetic Resonance Spectroscopy (MRS) evaluates the chemical composition and metabolic activity of brain tissues, helping differentiate between tumor types, infection, radiation changes, and other neurological conditions.
This scan is particularly useful in diagnosing and characterizing brain tumors, assessing tumor grade, distinguishing recurrent tumor from post-treatment changes, and evaluating complex neurological disorders. It plays a vital role in treatment planning, monitoring response to therapy, and improving diagnostic accuracy.
The procedure is non-invasive, safe, and does not involve radiation, though it includes contrast administration.
This test is recommended for individuals:
- Suspected of brain tumors or lesions
- Undergoing evaluation of tumor type or grade
- With unexplained neurological symptoms
- Requiring differentiation between tumor and infection
- Undergoing follow-up after brain tumor treatment
- Requiring advanced brain imaging